MGC Diagnostics (MGCD) Getting Somewhat Negative Media Coverage, Report Shows

Press coverage about MGC Diagnostics (NASDAQ:MGCD) has been trending somewhat negative on Thursday, Accern Sentiment reports. The research group rates the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. MGC Diagnostics earned a coverage optimism score of -0.05 on Accern’s scale. Accern also assigned media headlines about the medical equipment provider an impact score of 47.069503245161 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

MGC Diagnostics (MGCD) remained flat at $$11.03 during mid-day trading on Thursday. The stock had a trading volume of 4,300 shares, compared to its average volume of 15,965. MGC Diagnostics has a 1 year low of $6.24 and a 1 year high of $11.20. The company has a market capitalization of $48.68, a price-to-earnings ratio of -13.13 and a beta of 0.09.

COPYRIGHT VIOLATION NOTICE: “MGC Diagnostics (MGCD) Getting Somewhat Negative Media Coverage, Report Shows” was reported by Ticker Report and is owned by of Ticker Report. If you are viewing this piece of content on another publication, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3125691/mgc-diagnostics-mgcd-getting-somewhat-negative-media-coverage-report-shows.html.

About MGC Diagnostics

MGC Diagnostics Corporation is a medical technology company, which offers cardiorespiratory health solutions. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. It sells its products internationally through distributors and in the United States through a direct sales force targeting specialists located in hospitals, university-based medical centers, medical clinics, physician offices, pharmaceutical companies, medical device manufacturers and clinical research organizations (CROs).

Insider Buying and Selling by Quarter for MGC Diagnostics (NASDAQ:MGCD)

Receive News & Ratings for MGC Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MGC Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.